Acquisitions (Tables)

9 Months Ended

Sep. 30, 2011

Acquisitions

Components and allocation of consideration transferred in connection with the HPLC business

	HPLC
Consideration Transferred:
Cash paid	$	1.1
Stock issued	2.9
Cash acquired	(0.2		)
Total consideration transferred	$	3.8
Allocation of Consideration Transferred:
Accounts receivable	$	0.2
Inventory	1.3
Property, plant and equipment	0.2
Intangible assets	2.9
Liabilities assumed	(0.8		)
Total consideration transferred	$	3.8

Schedule of adjustments to allocation of consideration transferred for nano surfaces business

	Acquisition Date Fair Values, as Reported at December 31, 2010			Measurement Period Adjustments			Acquisition Date Fair Values, as Reported at September 30, 2011
Accounts receivable	$	21.8		$	—		$	21.8
Inventory	33.5			—			33.5
Other current assets	8.1			—			8.1
Property, plant and equipment	18.0			—			18.0
Intangible assets	110.5			2.0			112.5
Goodwill	51.0			(2.0		)	49.0
Liabilities assumed	(12.5		)	—			(12.5		)
	$	230.4		$	—		$	230.4

Schedule of pro forma financial information reflecting the acquisition of the nano surfaces business

	Three Months Ended September 30, 2010		Nine Months Ended September 30, 2010
Revenue	$	342.1	$	980.8
Net income attributable to Bruker Corporation	16.7		54.5
Net income per common share attributable to Bruker Corporation shareholders:
Basic and diluted	$	0.10	$	0.33